Ori Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ori Shen has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
R. Rabinowitz
Department of Obstetrics and Gynecology Shaare Zedek Medical Center Jerusalem Israel
5 shared publicationsRon Rabinowitz
Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel
4 shared publicationsM. Gal
Department of Genetics Shaare Zedek Medical Center Jerusalem Israel
3 shared publicationsS. Yagel
Department of Obstetrics and Gynecology Hadassah Mount Scopus Hospital Jerusalem Israel
3 shared publicationsAvi Tsafrir
Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Post Box 3125, Jerusalem 91031, Israel
2 shared publicationsO. Lavie
2 shared publications
Latest Publications
- 25 July 2016
- Published by Wiley in Prenatal Diagnosis
- Vol. 36 (9) , 894-895
Prenatal observation of nystagmus, cataracts, and brain abnormalities in a case of Zellweger spectrum disorder syndrome
- 25 July 2016
- Published by Wiley in Prenatal Diagnosis
- Vol. 36 (9) , 894-895
Prenatal observation of nystagmus, cataracts, and brain abnormalities in a case of Zellweger spectrum disorder syndrome
- 1 January 2016
- Vol. 18 (1) , 40-4
Fetal Biometry in the Israeli Population: New Reference Charts.
Selection of appropriate reference charts for fetal biometry is mandatory to ensure an accurate diagnosis. Most hospitals and clinics in Israel use growth curves from the United States. Charts developed in different populations do not perform well in the Israeli population. To construct new reference charts for fetal biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur length (FL), using a large sample of fetuses examined at 14-42 weeks gestational age in a medical center and a community ultrasound unit located in two different regions of Israel. Data from the medical center and the community clinic were pooled. The mean and standard error of each measure for each week was calculated. Based on these, reference charts were calculated using quantiles of the normal distribution. The performance of the reference charts was assessed by comparing the new values to empiric quantiles. Biometric measurements were obtained for 79,328 fetuses. Growth charts were established based on these measurements. The overall performance of the curves was very good, with only a few exceptions among the higher quantiles in the third trimester in the medical center subsample. We present new local reference charts for fetal biometry, derived from a large and minimally selected Israeli population. We suggest using these new charts in routine daily obstetric practice.
- 1 January 2016
- Vol. 18 (1) , 40-4
Fetal Biometry in the Israeli Population: New Reference Charts.
Selection of appropriate reference charts for fetal biometry is mandatory to ensure an accurate diagnosis. Most hospitals and clinics in Israel use growth curves from the United States. Charts developed in different populations do not perform well in the Israeli population. To construct new reference charts for fetal biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC) and femur length (FL), using a large sample of fetuses examined at 14-42 weeks gestational age in a medical center and a community ultrasound unit located in two different regions of Israel. Data from the medical center and the community clinic were pooled. The mean and standard error of each measure for each week was calculated. Based on these, reference charts were calculated using quantiles of the normal distribution. The performance of the reference charts was assessed by comparing the new values to empiric quantiles. Biometric measurements were obtained for 79,328 fetuses. Growth charts were established based on these measurements. The overall performance of the curves was very good, with only a few exceptions among the higher quantiles in the third trimester in the medical center subsample. We present new local reference charts for fetal biometry, derived from a large and minimally selected Israeli population. We suggest using these new charts in routine daily obstetric practice.
- 1 January 2016
- Published by Elsevier in Early Human Development
- Vol. 92, 25-28
Intrapartum fetal heart rate patterns of trisomy 21 fetuses: A case–control study
- 1 January 2016
- Published by Elsevier in Early Human Development
- Vol. 92, 25-28
Intrapartum fetal heart rate patterns of trisomy 21 fetuses: A case–control study
- 3 November 2015
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 46 (5) , 595-599
Abnormal shape of the cavum septi pellucidi: an indirect sign of partial agenesis of the corpus callosum
Objective: To describe and assess the presence of a new indirect sign of partial agenesis of the corpus callosum (pACC): an abnormally shaped cavum septi pellucidi (CSP).Methods: We analyzed retrospectively images from all 71 cases of pACC seen at two referral centers between September 2006 and April 2014. Abnormally shaped CSP was diagnosed when its lateral dimension was greater than its anteroposterior dimension in the axial transthalamic plane, and the incidence of this sign was assessed. We also examined the following variables: gestational age at referral, indication for referral, which (if any) of the four corpus callosal segments were abnormal, presence of other, previously established, indirect signs of callosal agenesis (ACC) and presence of additional cerebral or extracerebral anomalies.Results: In 56 of the 71 (79%) cases, the CSP was measurable; it was abnormally shaped in 19 (34%) of these cases, 15 (79%) of which had no other indirect signs of pACC. Of 23 cases with isolated pACC and no other indirect signs, 12 (52%) had an abnormally shaped CSP.Conclusions: In a significant proportion of cases of pACC detected prenatally, the shape of the CSP is abnormal. This should be considered an additional indirect sign of pACC, and is frequently the only clue to the diagnosis. When observing this sign in a screening context, pACC should be considered, and an attempt to visualize the corpus callosum directly in the midsagittal plane is suggested. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.
- 3 November 2015
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 46 (5) , 595-599
Abnormal shape of the cavum septi pellucidi: an indirect sign of partial agenesis of the corpus callosum
Objective: To describe and assess the presence of a new indirect sign of partial agenesis of the corpus callosum (pACC): an abnormally shaped cavum septi pellucidi (CSP).Methods: We analyzed retrospectively images from all 71 cases of pACC seen at two referral centers between September 2006 and April 2014. Abnormally shaped CSP was diagnosed when its lateral dimension was greater than its anteroposterior dimension in the axial transthalamic plane, and the incidence of this sign was assessed. We also examined the following variables: gestational age at referral, indication for referral, which (if any) of the four corpus callosal segments were abnormal, presence of other, previously established, indirect signs of callosal agenesis (ACC) and presence of additional cerebral or extracerebral anomalies.Results: In 56 of the 71 (79%) cases, the CSP was measurable; it was abnormally shaped in 19 (34%) of these cases, 15 (79%) of which had no other indirect signs of pACC. Of 23 cases with isolated pACC and no other indirect signs, 12 (52%) had an abnormally shaped CSP.Conclusions: In a significant proportion of cases of pACC detected prenatally, the shape of the CSP is abnormal. This should be considered an additional indirect sign of pACC, and is frequently the only clue to the diagnosis. When observing this sign in a screening context, pACC should be considered, and an attempt to visualize the corpus callosum directly in the midsagittal plane is suggested. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.
- 2 July 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 44 (1) , 119
Re: Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis.
- 2 July 2014
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 44 (1) , 119
Re: Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis.
- Open Access
- 23 April 2014
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 3 (2) , 432-439
Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
The aim of this study was to examine if isolated fetal ventricular septal defect (VSD) is associated with trisomy 21. One hundred twenty six cases with prenatal VSD diagnosed by a pediatric cardiologist were reviewed. Cases with known risk factors for congenital heart disease, the presence of other major anomalies, soft signs for trisomy 21 or a positive screen test for trisomy 21 were excluded. Ninety two cases formed the study group. None of the cases in the study group had trisomy 21. The upper limit of prevalence for trisomy 21 in isolated VSD is 3%. When prenatal VSD is not associated with other major anomalies, soft markers for trisomy 21 or a positive nuchal translucency or biochemical screen, a decision whether to perform genetic amniocentesis should be individualized. The currently unknown association between isolated VSD and microdeletions and microduplications should be considered when discussing this option.
- 23 April 2014
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 3 (2) , 432-439
Open AccessPrenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
The aim of this study was to examine if isolated fetal ventricular septal defect (VSD) is associated with trisomy 21. One hundred twenty six cases with prenatal VSD diagnosed by a pediatric cardiologist were reviewed. Cases with known risk factors for congenital heart disease, the presence of other major anomalies, soft signs for trisomy 21 or a positive screen test for trisomy 21 were excluded. Ninety two cases formed the study group. None of the cases in the study group had trisomy 21. The upper limit of prevalence for trisomy 21 in isolated VSD is 3%. When prenatal VSD is not associated with other major anomalies, soft markers for trisomy 21 or a positive nuchal translucency or biochemical screen, a decision whether to perform genetic amniocentesis should be individualized. The currently unknown association between isolated VSD and microdeletions and microduplications should be considered when discussing this option.
- 1 March 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (3) , 541-544
Omega-Shaped Variant of the Umbilical Artery
- 1 March 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (3) , 541-544
Omega-Shaped Variant of the Umbilical Artery
- 24 October 2012
- Published by Wiley in Prenatal Diagnosis
- Vol. 32 (11) , 1119-1120
Comment on “Relationship of nonvisualization of the fetal gallbladder and amniotic fluid digestive enzymes analysis to outcome”
- 24 October 2012
- Published by Wiley in Prenatal Diagnosis
- Vol. 32 (11) , 1119-1120
Comment on “Relationship of nonvisualization of the fetal gallbladder and amniotic fluid digestive enzymes analysis to outcome”
- 28 July 2011
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 38 (2) , 238-240
Reply
- 1 June 2011
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 30 (6) , 827-831
Sonographic Examination of the Fetal Vermis
- 1 June 2011
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 30 (6) , 827-831
Sonographic Examination of the Fetal Vermis